July 2024 in “Journal of Investigative Dermatology” Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.
April 2024 in “Journal of burn care & research” This study found that most patients with burn scar alopecia chose to pursue multiple surgical treatments regardless of total body surface area affected or gender, highlighting the importance of personalized aesthetic goals in post-burn care.
July 2023 in “IntechOpen eBooks” This review highlights that alopecia areata, a common type of hair loss, currently lacks preventive or curative treatments, and traditional therapies such as minoxidil and corticosteroids offer inconsistent results, necessitating patient-consensual treatment planning.
6 citations
,
August 2023 in “Fertility and Sterility” This review details the 2023 International Guideline update for assessing and managing polycystic ovary syndrome, which provides evidence-based recommendations to improve care and patient outcomes but notes the remaining low to moderate quality of evidence.
December 2023 in “Journal of dermatology” This study found that adult and adolescent patients with alopecia areata in the US and Europe are willing to accept significant risks of serious side effects, such as infection and cancer, to achieve effective hair regrowth with Janus kinase inhibitors.
17 citations
,
July 2006 in “The International Journal of Health Planning and Management” This article discusses strategies for healthcare organizations to navigate environmental challenges and competitive forces, emphasizing the need for focused strategic positioning and adaptable activity sets, but reports no new empirical results.
1 citations
,
July 2017 in “Frontiers in Communication” This study found that the urgency of self-triage decisions can be influenced by whether a disorder is presented using newer medical terminology rather than lay terms.
5 citations
,
February 2024 in “Clinical Pharmacokinetics” This study found that modeling and simulation effectively informed decision-making and dose selection for ritlecitinib in treating alopecia areata, supporting an accelerated drug development strategy.
2 citations
,
January 2020 in “Journal of Experimental Social Psychology” This study found that men with male pattern baldness are perceived as older, and shaving heads increased perceived dominance, but neither influenced leader preference in different contexts.
February 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This analysis highlighted the importance of integrating scientific literacy into chemical hair procedures, emphasizing that understanding the interaction of chemical agents with hair's biological structure and making evidence-based decisions can improve safety, predictability, and professional standards in the beauty industry.
February 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights the complex role of scientific knowledge and professional expertise in safely performing chemical hair procedures, emphasizing the importance of education to prevent potential adverse effects like hair damage and scalp irritation.
September 2025 in “Value in Health”
July 2026 in “Journal of Ovarian Research” In this review, researchers provided a comprehensive analysis of anti-androgen therapies for polyendocrine metabolic ovarian syndrome (PMOS/PCOS), examining their efficacy and safety while proposing a phenotype-guided management framework and highlighting research gaps, such as long-term cardiovascular safety and predictive biomarkers.
August 2025 in “International Journal of Dermatology” This research underscores the critical need to recognize and study how the fear or reality of hair loss profoundly influences patients' medical decisions, including refusing cancer treatments or altering reproductive plans.
November 2024 in “Journal of Investigative Dermatology” Inherited ichthyosis negatively impacts quality of life, affecting daily activities, self-image, and reproductive decisions.
February 2026 in “Pharmaceuticals” This study introduced the KRDQN predictive framework, which outperformed existing methods in predicting adverse drug reactions and provided interpretable insights into drug mechanisms, aiding pharmacovigilance and clinical decision-making.
35 citations
,
June 2005 in “The Milbank Quarterly” This article describes a framework for evaluating new health technologies by integrating quantitative evidence with qualitative assessments and using precedents to guide policy decisions, without reporting new clinical results.
May 2019 in “Cytotherapy” This study explored how Australian patients and their carers perceived autologous stem cell interventions, highlighting factors like illness experience and unrealistic expectations that influenced their decision-making in an unregulated market.
3 citations
,
January 2019 in “Elsevier eBooks” This article discusses the importance of interpreting laboratory data and performing physical assessments to support pharmacists in clinical decision-making and patient consultations, but reports no new empirical findings.
February 2026 in “Frontiers in Pharmacology” This review suggests a shift toward genetically informed treatments for male pattern hair loss by integrating genetic insights and pharmacogenetic markers into therapeutic decision-making.
August 2025 in “BMC Pregnancy and Childbirth” In this study, prenatal ultrasonography was found to be a valuable tool for screening ectodermal dysplasia during pregnancy, and a new EDA gene variant associated with X-linked hypohidrotic ectodermal dysplasia was identified, aiding in more accurate diagnoses and reproductive decision-making.
254 citations
,
September 2014 in “Menopause” The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.
September 2023 in “Family practice” This study found that among 52 classification tools on the Clinical Knowledge Summaries website, 46% lacked strong guidance for their use in managing conditions, suggesting that nearly half of the tools may not be useful for clinical decision-making.
1 citations
,
September 2025 in “Cureus” In this study, the ChatGPT-5 model accurately answered 76.47% of questions on the Polish endocrinology specialty exam, surpassing the 60% passing threshold, yet its role in clinical decision-making remains uncertain, highlighting the need for further research.
April 2026 in “Frontiers in Medicine” In this case report, a female patient with both psoriasis and lichen planus initially responded to acitretin and topical mometasone but experienced a relapse after stopping the treatment. The authors reported marked improvement within 3 months after switching to upadacitinib, aiming to guide clinical decision-making.
July 2026 in “International Journal of Advanced Research in Science Communication and Technology” In this study, the BaldGraphFormer framework, integrating visual and clinical data, outperformed unimodal baselines in early-stage androgenetic alopecia detection, achieving an F1-score of 97.62% and macro-average AUC of 0.992, suggesting its potential to support dermatological decision-making and early intervention.
4 citations
,
April 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This book reviews interdisciplinary strategies for sustainable development, emphasizing integrative approaches that combine environmental, social, and economic pillars in decision-making but reports no new research results.
1 citations
,
May 2013 in “Oncology Times” This narrative review reflects on the challenges faced by FDA's Oncologic Drugs Advisory Committee members, highlighting public pressure, decision-making complexity, and the evolving landscape of cancer drug development.
4 citations
,
September 2024 in “Skin Research and Technology” This study provides a comprehensive overview of the current state and emerging trends in SD (seborrheic dermatitis) research, aimed at aiding clinical practitioners and researchers in understanding valuable insights for decision-making and identifying future research directions.
1 citations
,
January 2024 in “Frontiers in Psychology” In this study, researchers found that venture capitalists with below-average physical attractiveness are more influenced by the attractiveness of entrepreneurs when making investment decisions, and this sensitivity changes between investment rounds.